Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

CRDF US Equity

Cardiff Oncology, Inc.Health Care · Biological Products, (No Diagnostic Substances) · CIK 1213037 · FY ends Dec 31
$0.90
+0.01 (+1.33%)
USD · as of 2026-08-19 · marketstack
2 8-K filings · 0 13D · 1 13G
DateEventWhat happened / filerSource
2026-08-118-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-07-2713G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by BlackRock, Inc.sec.gov ↗
2026-07-168-K 8.01Other eventssec.gov ↗
2026-07-168-K 1.01Entry into a material definitive agreementsec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-16

Every row is a filed document, checked against its EDGAR index.